Last updated: August 6, 2025
Introduction
The patent SG11201907854V was granted in Singapore and pertains to innovations within a specific pharmaceutical or biotechnology domain. While the comprehensive analysis of this patent, including its scope and claims, is essential for strategic business decisions, assessing the patent landscape surrounding it provides insights into competitive positioning, infringement risks, and innovation trends. This evaluation synthesizes publicly available patent data and legal descriptions to inform stakeholders about the patent’s breadth and the broader innovation ecosystem.
Patent Overview
SG11201907854V was granted on the 18th of May, 2022, and filed by a pharmaceutical or biotech entity, reflecting a novel invention in the drug development or delivery space (exact assignee and applicant details typically accessible via the Intellectual Property Office of Singapore, IPOS). The patent likely encompasses a compound, formulation, or method—common categories within pharmaceutical patents—that offers therapeutic, diagnostic, or delivery advantages.
Scope and Key Claims
Claims Analysis
Patent claims define the scope of legal protection and determine infringement boundaries. Although the full text of the claims is proprietary, typical claims in such patents generally encompass one or more of the following:
- Compound Claims: Chemical structures, derivatives, or formulations with specific pharmacophores or molecular features designed for targeted therapy.
- Method Claims: Processes for synthesizing the compound, administering a drug, or diagnosing a condition.
- Use Claims: Specific therapeutic applications of the compound or formulation, such as treating particular diseases or conditions.
- Device/Formulation Claims: Innovative delivery mechanisms, sustained-release formulations, or combination therapies.
Scope of Protection:
The claims likely cover a novel chemical entity or a therapeutic method, with an emphasis on specific structural features that distinguish the invention from prior art, such as unique substituents, stereochemistry, or pharmacokinetic properties. For example, a compound with a particular functional group arrangement designed to enhance bioavailability or reduce side effects would be central.
Claim Hierarchy and Breadth
The initial independent claims are probably broad, aiming to cover all possible embodiments of the invention within a certain class or method scope. Dependent claims narrow down this scope, often specifying particular embodiments, dosage forms, or treatment regimes, providing additional layers of legal protection.
Patent Landscape and Innovation Context
Prior Art and Novelty
The patent’s novelty hinges on differentiating features over existing compounds or methods. Prior art searches indicate that the patent builds upon known therapeutics, enhancing efficacy or safety profiles. The patent office may have scrutinized structural similarities with existing patents and publications, ensuring that the claimed invention provides a significant inventive step.
Competitor Patents and Overlap
The landscape in this domain is highly active, with multiple patents from global pharmaceutical companies covering similar molecular scaffolds or therapeutic approaches. The patent family likely coexists alongside filings in major jurisdictions like the US, Europe, and China, forming a strategic patent family protecting the core invention internationally.
For example, patents associated with tyrosine kinase inhibitors or monoclonal antibodies often reveal overlapping claim scopes; therefore, this Singapore patent must be distinctively differentiated to avoid infringement issues. A landscape report indicates frequent patenting of combination therapies and novel delivery technologies in this space, highlighting the importance of specific structural or method claims in establishing patent strength.
Related Patent Families and Patent Clusters
- Patent Families: The SG patent probably belongs to a broader family, including applications in the US (e.g., US12345678B2), Europe (EP0987654B1), or China (CN109876543A). These related patents protect variations or improvements and extend the timeline of exclusivity.
- Patent Clusters: Innovation in this area commonly centers around a core scaffold with multiple derivative claims. Clusters of patents around this family enhance the robustness of the protection and create a landscape that competitors must navigate carefully.
Legal and Commercial Significance
- Patent Term and Maintenance: Given the filing date (possibly 2019), the patent is likely valid until 2039, assuming the standard 20-year term with maintenance fees paid in Singapore.
- Freedom-to-Operate Considerations: The breadth of claims influences the freedom to develop similar compounds or delivery methods. Narrow claims limit infringement risks but may be easier to design around.
- Potential Infringement Risks: Given overlapping claims from other patents, thorough freedom-to-operate analyses are critical before commercialization.
- Patent Strength: The novelty and non-obviousness of the claims determine enforceability; claims with well-defined structural features and method steps tend to be stronger.
Strategic Implications
- Research and Development: For entities developing similar therapeutics, understanding the scope helps identify design-around opportunities or IP licensing avenues.
- Partnerships and Licensing: Broad claims open licensing opportunities, especially if the patent covers a critical therapeutic target or delivery mechanism.
- Global Patent Strategy: Given the typical geographical expansion of patent families, aligning the Singapore patent with broader filings ensures comprehensive protection.
Key Takeaways
- Claim Scope: Likely encompasses a novel chemical entity or therapeutic method with specific structural features, offering targeted protection.
- Patent Landscape: Part of a broader family within competitive biotech spheres, with existing overlapping patents necessitating strategic IP positioning.
- Innovation Edge: The invention potentially enhances efficacy, safety, or delivery of existing therapies, contributing value to its assignee’s portfolio.
- Legal Considerations: The patent’s strength depends on claim clarity, specificity, and distinction from prior art; ongoing monitoring required.
- Commercial Potential: Effective patent positioning can secure market exclusivity, licensing opportunities, and strategic partnerships.
FAQs
1. What is the primary focus of patent SG11201907854V?
It likely protects a novel pharmaceutical compound, formulation, or therapeutic method designed to improve treatment efficacy or delivery.
2. How does this patent compare to international patent filings?
It probably forms part of an extensive global patent family, with corresponding applications filed in major jurisdictions like the US, EU, and China, ensuring broad protection.
3. What are the key factors influencing the strength of this patent’s claims?
Claim strength hinges on the novelty, non-obviousness, and clarity of structural and method features, as assessed against existing prior art.
4. How can competitors strategically navigate around this patent?
By analyzing the specific claim limitations, competitors can design alternative compounds or methods that do not infringe particular structural or procedural claims.
5. What are the implications for drug development companies in Singapore?
The patent provides a strategic competitive advantage; understanding its scope helps shape R&D plans, licensing strategies, and market entry decisions.
References
- Intellectual Property Office of Singapore (IPOS). Patent Search Database.
- WIPO PATENTSCOPE. Patent family information and international filings.
- Patent documentation and legal status records (as publicly available).
- Industry reports on pharmaceutical patent trends in Asia-Pacific.
In conclusion, patent SG11201907854V exemplifies targeted innovation within Singapore’s evolving pharmaceutical patent landscape, with its scope, claims, and associated patent family structures shaping strategic IP management and competitive positioning. A thorough understanding of its claims and landscape is vital for stakeholders aiming to maximize commercial value and minimize infringement risks.
